Compare Stocks › ABBV vs NVDA

AbbVie Inc. (ABBV) vs NVIDIA Corporation (NVDA): Which Is the Better Buy in 2026?

As of 2026-11-02, ABBV is overvalued at $295, with a DCF intrinsic value of $177 and a margin of safety of -67%. NVDA is overvalued at $205, with an intrinsic value of $163 and a margin of safety of -25%. Of the two, NVDA has the wider margin of safety.

ABBV
AbbVie Inc.
$294.89
VS
NVDA
NVIDIA Corporation
$204.64

Rewards

ABBV
  • ★AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 73.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
NVDA
  • ★NVIDIA Corporation has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • ★Gross margin of 74.7% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • ★Free cash flow has grown at a 193.9% CAGR over the past 4 years, demonstrating strong earnings power growth.

Risks

ABBV
  • ⚠Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • ⚠Insiders have sold $8.2M worth of stock in the past 3 months — significant insider liquidation.
  • ⚠Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
NVDA
  • ⚠FCF yield of 2.0% is below 3%, meaning the market is pricing in substantial future growth to justify the current price.
  • ⚠Beneish M-Score of -1.06 flags financial patterns consistent with potential earnings manipulation — warrants further investigation.

Key Valuation Metrics

Learn more →
ABBV
NVDA
Valuation
N/A
Free Cash Flow
$96.68B
N/A
FCF Yield
1.96%
50.67
Trailing P/E
25.87
18.23
Forward P/E
12.86
Quality & Moat
29.08%
ROIC
59.19%
N/A
ROE
117.21%
73.72%
Gross Margin
74.67%
0.60
PEG Ratio
0.25
Balance Sheet Safety
N/A
Net Debt / Equity
Net cash
N/A
Interest Coverage
N/A
2.03
Net Debt / EBITDA
-0.12
2.35%
Dividend Yield
0.49%
ABBV: 1Ties: 2NVDA: 5
ABBVNVDA

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

NVDA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
NVDA
$17.02
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$220.50B
Δ Market Cap
+$3.75T
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
66.6% Overvalued
Price is 66.6% above estimated fair value
Current Price: $294.89
Fair Value: $177.00
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
NVDA
46.0% Margin of Safety
Price is 46.0% below estimated fair value
Current Price: $204.64
Fair Value: $378.65
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

NVDA

What growth rate is the market pricing in at $205?

+17.5%
Market-Implied Owner Earnings Growth
Standard FCF implies +20.4%

The market implies +17.5% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +20.4%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
NVDA
69/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with roic consistency as the key competitive advantage. Improving revenue predictability would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
NVDA
-1.06
Likely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 77.4%Retail & Other 22.5%
No. of Institutional Holders5,303
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
NVDA
Insiders 4.0%Institutions 71.5%Retail & Other 24.5%
No. of Institutional Holders7,728
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
NVDA
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
1
Sells (3M)
4
Sells (12M)
Total value (12M): $18.92M
DONOGHOE NICHOLAS
Officer
$8.18M
@ $250.00 · 2026-08-14
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
NVDA
0
Sells (3M)
7
Sells (12M)
Total value (12M): $24.72M
DABIRI JOHN O
Director
$133,750
@ $214.00 · 2026-05-27
ROBERTSON DONALD F JR
Officer
$942,944
@ $174.75 · 2026-03-20
SHAH AARTI S
Director
$3.36M
@ $176.71 · 2026-03-19
DABIRI JOHN O
Director
$555,440
@ $184.90 · 2026-03-13
ROBERTSON DONALD F JR
Officer
$15.19M
@ $189.85 · 2026-01-02
ROBERTSON DONALD F JR
Officer
$4.43M
@ $179.98 · 2025-12-19
DABIRI JOHN O
Director
$112,317
@ $179.42 · 2025-11-24
HUANG JEN-HSUN
Chief Executive Officer
$5.20M
@ $207.91 · 2025-10-29
HUANG JEN-HSUN
Chief Executive Officer
$23.56M
@ $188.47 · 2025-10-28
HUANG JEN-HSUN
Chief Executive Officer
$40.73M
@ $181.04 · 2025-10-23
HUANG JEN-HSUN
Chief Executive Officer
$41.06M
@ $182.48 · 2025-10-20
HUANG JEN-HSUN
Chief Executive Officer
$41.34M
@ $183.73 · 2025-10-15
HUANG JEN-HSUN
Chief Executive Officer
$42.89M
@ $190.60 · 2025-10-10
HUANG JEN-HSUN
Chief Executive Officer
$42.05M
@ $186.89 · 2025-10-07
HUANG JEN-HSUN
Chief Executive Officer
$42.09M
@ $187.08 · 2025-10-02
HUANG JEN-HSUN
Chief Executive Officer
$40.23M
@ $178.82 · 2025-09-29
HUANG JEN-HSUN
Chief Executive Officer
$40.21M
@ $178.69 · 2025-09-24
ROBERTSON DONALD F JR
Officer
$617,298
@ $176.37 · 2025-09-19
HUANG JEN-HSUN
Chief Executive Officer
$39.18M
@ $174.14 · 2025-09-19
HUANG JEN-HSUN
Chief Executive Officer
$39.75M
@ $176.66 · 2025-09-16
HUANG JEN-HSUN
Chief Executive Officer
$39.28M
@ $174.59 · 2025-09-11
HUANG JEN-HSUN
Chief Executive Officer
$38.01M
@ $168.95 · 2025-09-08
HUANG JEN-HSUN
Chief Executive Officer
$38.61M
@ $171.60 · 2025-09-03
HUDSON BEACH DAWN E
Director
$15.38M
@ $170.90 · 2025-09-03
HUANG JEN-HSUN
Chief Executive Officer
$27.12M
@ $180.79 · 2025-08-15
HUANG JEN-HSUN
Chief Executive Officer
$40.96M
@ $182.04 · 2025-08-13
HUANG JEN-HSUN
Chief Executive Officer
$40.66M
@ $180.70 · 2025-08-08
HUANG JEN-HSUN
Chief Executive Officer
$39.78M
@ $176.80 · 2025-08-05
HUANG JEN-HSUN
Chief Executive Officer
$40.18M
@ $178.58 · 2025-07-31
HUANG JEN-HSUN
Chief Executive Officer
$39.16M
@ $174.02 · 2025-07-28
HUANG JEN-HSUN
Chief Executive Officer
$38.22M
@ $169.87 · 2025-07-23
HUANG JEN-HSUN
Chief Executive Officer
$38.71M
@ $172.05 · 2025-07-18
HUANG JEN-HSUN
Chief Executive Officer
$37.59M
@ $167.08 · 2025-07-15
HUANG JEN-HSUN
Chief Executive Officer
$36.43M
@ $161.91 · 2025-07-10
HUANG JEN-HSUN
Chief Executive Officer
$35.55M
@ $158.02 · 2025-07-07
HUANG JEN-HSUN
Chief Executive Officer
$35.16M
@ $156.27 · 2025-07-01
HUANG JEN-HSUN
Chief Executive Officer
$30.47M
@ $152.33 · 2025-06-26
HUANG JEN-HSUN
Chief Executive Officer
$14.40M
@ $144.04 · 2025-06-23
ROBERTSON DONALD F JR
Officer
$646,469
@ $143.66 · 2025-06-20
DABIRI JOHN O
Director
$91,608
@ $138.80 · 2025-05-30
BURGESS ROBERT KENNETH
Director
$6.74M
@ $134.82 · 2025-05-30
KRESS COLETTE M.
Chief Financial Officer
$7.79M
@ $116.83 · 2025-03-21
ROBERTSON DONALD F JR
Officer
$525,585
@ $116.80 · 2025-03-21
SHAH AARTI S
Director
$2.37M
@ $118.42 · 2025-03-20
BURGESS ROBERT KENNETH
Director
$6.16M
@ $115.49 · 2025-03-13
DABIRI JOHN O
Director
$292,930
@ $110.00 · 2025-03-10
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(72/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
NVDA
FearGreed
😐Neutral(48/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (72)
NVDA
⚪Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (48)
View ABBV Full AnalysisView NVDA Full Analysis

Frequently Asked Questions: ABBV vs NVDA

Is AbbVie Inc. or NVIDIA Corporation more undervalued in 2026?▼

Based on our discounted cash flow model, NVDA trades at a -25.5% margin of safety (intrinsic value $163 vs. price $205), compared to ABBV's -66.6% margin of safety (intrinsic $177 vs. $295).

Which stock has a wider economic moat, AbbVie Inc. or NVIDIA Corporation?▼

ABBV scores 82/100 (Wide moat), while NVDA scores 69/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?▼

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. NVDA scores 4.7 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or NVIDIA Corporation?▼

NVDA earns 59.2% ROIC versus ABBV's 29.1%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or NVIDIA Corporation's?▼

NVDA's dividend earns a safety score of 91/100 (Very Safe), compared to ABBV's 39/100 (Unsafe). NVDA has raised its dividend for 2 consecutive years.

Does NVIDIA Corporation have accounting red flags?▼

NVDA's Beneish M-Score of -1.1 flags it as a likely earnings manipulator (above the -1.78 threshold). By contrast, ABBV scores -2.9, within the normal range. The Beneish model detects aggressive accounting through eight financial ratios.

ABBV vs NVDA: Which Is the Better Buy in 2026? | SafetyMargin.io